Levey R H, Parkman R, Rappeport J, Nathan D G, Rosen F
Transplant Proc. 1979 Mar;11(1):199-204.
Fourteen patients with aplastic anemia and one with the Wiskott-Aldrich syndrome who were specifically sensitized against their donors were successfully engrafted with bone marrow from those donors. Sensitivity was detected in antibody-independent and antibody-dependent cell-mediated lysis assays. In order to erase this immunity to non-MHR familial transplantation antigens, multiagent immunosuppression with cyclophosphamide, procarbazine, and whole rabbit antithymocyte serum (ATS) was used. The data suggest that ATS was largely responsible for abrogation of this sensitivity and indicate that immunity does not represent a barrier to successful transplantation.
14例再生障碍性贫血患者和1例对供体产生特异性致敏的威斯科特-奥尔德里奇综合征患者成功接受了来自这些供体的骨髓移植。在非抗体依赖性和抗体依赖性细胞介导的裂解试验中检测到了敏感性。为了消除对非主要组织相容性复合体(MHC)家族移植抗原的这种免疫反应,使用了环磷酰胺、丙卡巴肼和全兔抗胸腺细胞血清(ATS)进行多药免疫抑制。数据表明,ATS在很大程度上导致了这种敏感性的消除,并表明免疫反应并不构成成功移植的障碍。